Tracking the ATYR option chain helps you see every strike and expiry on Atyr Pharma Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Atyr Pharma Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ATYR options activity at a glance. Use our scanner to monitor the ATYR option chain in real time and filter for the ATYR options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ATYR stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ATYR option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ATYR stock options are being actively traded and where they are not.
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders.
It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Atyr Pharma Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ATYR options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ATYR stock options — let the full option chain come to you, pre-filtered and ready to trade.
